Pegylated Interferon Alfa-2b
Showing 1 - 25 of 6,096
Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)
Recruiting
- Essential Thrombocytopenia
- Recombinant Interferon Alpha
- Pegylated interferon alfa-2b
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 18, 2022
Malignant Melanoma Trial in San Diego, Memphis, Houston (Peginterferon alfa-2b, Temozolomide, Recombinant interferon alfa-2b)
Active, not recruiting
- Malignant Melanoma
- Peginterferon alfa-2b
- +2 more
-
San Diego, California
- +2 more
Apr 1, 2022
Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b
Recruiting
- Hepatocellular Carcinoma
- Anti-PD-1/PD-L1
- PEG-Interferon Alfa
-
Shanghai, ChinaZhongshan Hospital, Fudan University
Mar 28, 2022
Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)
Completed
- Juvenile Pilocytic Astrocytomas
- Optic Pathway Gliomas
- Pegylated interferon alpha-2b
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Jan 18, 2022
Adult T-cell Leukemia-Lymphoma, ATLL Trial in Miami (Belinostat, Zidovudine, Interferon-Alfa-2b)
Recruiting
- Adult T-cell Leukemia-Lymphoma
- ATLL
- Belinostat
- +3 more
-
Miami, FloridaUniversity of Miami
Jan 24, 2022
Chronic Hepatitis B Trial in Shanghai (Hepalatide, Placebo of Hepalatide, Tenofovir Alafenamide Tablets)
Not yet recruiting
- Chronic Hepatitis B
- Hepalatide
- +3 more
-
Shanghai, Shanghai, China
- +1 more
Feb 16, 2022
Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)
Recruiting
- Hematological Neoplasms
- Recurrence
- Peg interferon alfa-2b
-
Shanghai, Shanghai, ChinaShanghai Jiao Tong University Affilated First People's Hospital
Oct 10, 2021
Chronic Hepatitis B Trial in Worldwide (VIR-2218, pegylated interferon-alfa 2a)
Active, not recruiting
- Chronic Hepatitis B
- VIR-2218
- pegylated interferon-alfa 2a
-
Birtinya, Queensland, Australia
- +21 more
Dec 20, 2021
HIV, Hepatitis C Trial in Puerto Rico, United States (Pegylated-Interferon Alfa 2b (PEG-IFN), Ribavirin (RBV), Boceprevir (BOC))
Completed
- HIV Infections
- Hepatitis C
- Pegylated-Interferon Alfa 2b (PEG-IFN)
- +2 more
-
Birmingham, Alabama
- +42 more
Nov 2, 2021
Hepatitis C, Chronic Trial (Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c)
Completed
- Hepatitis C, Chronic
- Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin
- Combination of (a) pegylated interferon alfa-2b and (b) ribavirin
- (no location specified)
Aug 24, 2020
HIV, Hepatitis B, Hepatitis C Trial (Adefovir dipivoxil, Peginterferon-alfa-2A, Ribavirin)
Withdrawn
- HIV Infections
- +2 more
- Adefovir dipivoxil
- +3 more
- (no location specified)
Oct 28, 2021
Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)
Recruiting
- Polycythemia Vera
- Ruxolitinib
- Pegylated interferon α-2b
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
May 19, 2023
Chronic Hepatitis B Virus Infection Trial in Worldwide (PEG-IFNa, BRII-835)
Not yet recruiting
- Chronic Hepatitis B Virus Infection
- PEG-IFNα
- BRII-835
-
Kingswood, New South Wales, Australia
- +28 more
Jul 21, 2023
Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)
Not yet recruiting
- Myelofibrosis
- Pegylated interferon alpha2a
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Sep 6, 2022
Hepatitis B, Chronic Trial in Worldwide (peginterferon alfa-2a [Pegasys])
Completed
- Hepatitis B, Chronic
- peginterferon alfa-2a [Pegasys]
-
San Francisco, California
- +38 more
Oct 26, 2022
Lymphoma, B-Cell Trial in Guangzhou (Rituximab Biosimilar, Pegylated Interferon a-2b)
Recruiting
- Lymphoma, B-Cell
- Rituximab Biosimilar
- Pegylated Interferon α-2b
-
Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat-sen University Cancer Ce
Apr 6, 2022
Cervical Dysplasia, HPV Infection Trial in Ulaanbaatar (gel Interferon arm, gel Interferon and interferon suppository arm)
Recruiting
- Cervical Dysplasia
- HPV Infection
- gel Interferon arm
- gel Interferon and interferon suppository arm
-
Ulaanbaatar, MongoliaNational Cancer Center
Nov 14, 2023
Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,
Completed
- Metastatic Carcinoma in the Liver
- +4 more
- Celecoxib
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 25, 2022
Chronic Hepatitis C Genotype 1 Trial (Boceprevir, Placebo, peginterferon alfa-2b)
Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)
Active, not recruiting
- Triple -Negative Breast Cancer
- +4 more
- Biopsy
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Aug 1, 2022
Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)
Recruiting
- Hepatitis B, Chronic
- PEGylated recombinant human interferon alpha-2b injection
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of Anhui Medical University
Jun 24, 2023
HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1
Recruiting
- HLA-A2 Positive Cells Present
- Refractory Melanoma
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 12, 2022